Ever Supreme Bio Technology Co., Ltd.
Industry Group: Pharmaceuticals
Country/Region: Taiwan
Identifier: ROCO:6712
Ever Supreme Bio Technology Co Ltd is a Taiwan-based company. The company is engaged in research, developing, and manufacturing new drugs related to human mesenchymal stem cells and immune cells. Its principal source of revenue is from providing cell therapy products required by the Special Regulations for Cell Therapy and Gene Therapy Products, selling genetic testing products, providing cell storage services, and commissioned research.
ESG Risk Rating
Ranking
Industry Group (1st = lowest risk)
Pharmaceuticals 443 out of 851
Universe
Global Universe 10464 out of 15094
What are the ESG Risk Ratings?
Notice: The information is provided as is, for informational, non-commercial purposes only, does not constitute investment advice and is subject to conditions available in our Legal Disclaimer. They are not directed to, or intended for distribution to or use by India-based clients or users and their distribution to Indian resident individuals or entities is not permitted. Usage of this information is not permitted in any way, unless otherwise agreed in writing. By way of exception, usage of this information is permitted to the rated subject, limited to a single reference to the score on the rated subject’s sustainability webpage or CSR report, mentioning Sustainalytics as a source. For referencing Sustainalytics please consult the Company Guide.
Industry Comparison
| Company | ESG Risk Rating | Industry Rank |
|---|---|---|
| PharmaEngine, Inc. |
20.6
Medium
|
95 out of 851 |
| Prime Medicine, Inc. |
27.7
Medium
|
337 out of 851 |
| Ever Supreme Bio Technology Co., Ltd. |
29.9
Medium
|
443 out of 851 |
| Alphamab Oncology |
32.6
High
|
553 out of 851 |
| Cartesian Therapeutics, Inc. |
36.4
High
|
719 out of 851 |
For corporate professionals interested in direct competitor insights
Sustainalytics' Peer Performance Insights gives an in-depth analysis of your company's ESG strengths and weaknesses compared to your competitors and industry performance. These insights can be used to identify areas of ESG improvement to help inform future management decisions that align with your organization's sustainability goals.
Our Approach to Calculating ESG Risk
The ESG Risk Ratings measure a company's exposure to industry-specific material ESG risks and how well a company is managing those risks.
Exposure
Exposure refers to the extent to which a company is exposed to different material ESG issues. Our exposure score takes into consideration subindustry and company-specific factors such as its business model.
Management
Management refers to how well a company is managing its relevant ESG issues. Our management score assesses the robustness of a company's ESG programs, practices and policies.